Erratum to: Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: Quality control, comparisons, and variability (Invest Ophthalmol Vis Sci, (2014) 55, (8180-8188), 10.1167/iovs.14-14960;Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: Quality control, comparisons, and variability

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 12, 2014, Pages 8180-8188

  Kupersmith, Mark J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Intracranial hypertension; OCT; Optical coherence tomography; Papilledema

Indexed keywords

ARTICLE; B SCAN; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OPTIC DISK; OPTIC NERVE; PAPILLEDEMA; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA MACULA LUTEA; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; ADULT; ALGORITHM; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; INTRACRANIAL HYPERTENSION; MIDDLE AGED; MULTICENTER STUDY; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROSPECTIVE STUDY; QUALITY CONTROL; REPRODUCIBILITY; STANDARDS; YOUNG ADULT;

ADULT; ALGORITHMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; MACULA LUTEA; MALE; MIDDLE AGED; NERVE FIBERS; OPTIC DISK; PAPILLEDEMA; PROSPECTIVE STUDIES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84917706932     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14960a     Document Type: Erratum

References (31)

1. Corbett J, Savino P, Thompson H, et al. Visual loss in pseudotumor cerebri: follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461-474.
2. Wall M, George D. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain. 1991;114:155-180.
3. Garrett J, Corbett JJ, Braswell RA, Santiago M. The increasing incidence of IIH. The effect of obesity on frequency of occurrence in Mississippi. Ann Neurol. 2004;56(suppl 8): S69.
4. The NORDIC Idiopathic Intracranial Hypertension Study Group. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the Idiopathic Intracranial Hypertension Treatment Trial. JAMA. 2014;311:1641-1651.
5. Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatr. 1982;45:13-18.
6. Scott C, Kardon R, Lee A, Frisén L, Wall M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010;128:705-711.
7. Sinclair A, Burdon M, Nightingale P, et al. Rating papilloedema: an evaluation of the Fris´en classification in idiopathic intracranial hypertension. J Neurol. 2012;259:1406-1412.
8. Echegaray S, Zamora G, Yu H, Luo W, Soliz P, Kardon R. Automated analysis of optic nerve images for detection and staging of papilledema. Invest Ophthalmol Vis Sci. 2011;52: 7470-7478.
9. Tang L, Kardon RH, Wang JK, Garvin MK, Lee K, Abramoff MD. Quantitative evaluation of papilledema from stereoscopic color fundus photographs. Invest Ophthalmol Vis Sci. 2012; 53:4490-4497.
10. Schuman JS, Hee MR, Arya AV, et al. Optical coherence tomography: a new tool for glaucoma diagnosis. Curr Opin Ophthalmol. 1995;6:89-95.
11. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963-969.
12. Talman L, Bisker E, Sacket D, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67:749-760.
13. Skau M, Sander B, Milea D, Jensen R. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol. 2011;258:277-283.
14. Skau M, Milea D, Sander B, Wegner M, Jensen R. OCT for optic disc elevation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2011;249:723-730.
15. Wang JK, Kardon RH, Kupersmith MJ, Garvin MK. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:4069-4075.
16. Garvin M, Abrámoff M, Kardon R, Russell S, Wu X, Sonka M. Intraretinal layer segmentation of macular optical coherence tomography images using optimal 3-D graph search. IEEE Trans Med Imaging. 2008;27:1495-1505.
17. Friedman D, McDermott M, Kieburtz K, et al.; for the NORDIC IIHTT Study Group. The Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): design considerations and methods. J Neuroophthalmol. 2014;34:107-117.
18. Mwanza J, Oakley J, Budenz D, Anderson D. Cirrus optical coherence tomography normative database study group: ability of Cirrus HD-OCT optic nerve head parameters to discriminated normal from glaucomatous eyes. Ophthalmology. 2011;118:241-248.
19. Kupersmith M, Sibony P, Mandel G, Durbin M, Kardon R. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary RPE layer in papilledema. Invest Ophthalmol Vis Sci. 2011;52:6558-6564.
20. Sibony P, Kupersmith M, Rohlf FJ. Geometric morphometrics of the peripapillary SD-OCT: shape analysis of the RPE layer in papilledema and ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2011;52:7987-7995.
21. Domalpally A, Blodi B, Scott IU, et al.; for the SCORE Study Investigator Group. The standard care vs corticosteroid for retinal vein occlusion (SCORE) study system for evaluation of optical coherence tomograms. Arch Ophthalmol. 2009;127: 1461-1467.
22. Costa R, Calucci D, Skaf M, et al. Optical coherence tomography 3: automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci. 2004;45:2399-2406.
23. Ishikawa H, Piette S, Liebmann J, Ritch R. Detecting the inner and outer borders of the retinal nerve fiber layer using optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2002;240:362-371.
24. Wu Z, Vazeen M, Varma R, Sadda S. Factors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomography. Ophthalmology. 2007;114:1505-1512.
25. Ray R, Stinnett S, Jaffe G. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol. 2005;139:18-29.
26. Sadda S, Wu Z, Walsh A, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology. 2006;113:285-293.
27. Keltner, J, Cello K, Balcer L, Calabresi P, Markowitz C, Werner JS. Stratus OCT quality control in two multi-centre multiple sclerosis clinical trials. Neuroophthalmol. 2011;35:57-64.
28. Wall M, White W. Asymmetric papilledema in idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci. 1998; 39:134-142.
29. Kirkham T, Saunders M, Sapp G. Unilateral papilledema in benign intracranial hypertension. Can J Ophthalmol. 1973;8: 533-538.
30. Huna-Baron R, Landau K, Rosenberg M, Warren F, Kupersmith MJ. Unilateral swollen disc due to increased intracranial pressure. Neurology. 2001;56:1588-1590.
31. El-Dairi M, Holgado S, O’Donnell T, Buckley E, Asrani S, Freedman S. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS. 2007;11: 564-570.